Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
FDA approves DESMODA, the first ready-to-use liquid medicine for central diabetes insipidus. It helps stop extreme thirst & frequent peeing with easier, safer precise dosing for kids & adults.
The US Department of Commerce is hosting a key roundtable with American robot makers on March 10, 2026, to tackle supply chain issues and policies amid growing competition from China in robotics and humanoids.
Citi hikes price targets on Lumentum to $800 and Corning to $170, citing strong roles in AI networking ahead of the key Optical Fiber Communication conference in March 2026.
United Therapeutics announces Tresmi, a revolutionary soft mist inhaler version of Treprostinil that cuts coughing side effects by up to 90%. Planned approval filing this year and launch next year, impacting strategic partner MannKind's stock.
Zimbabwe suddenly bans raw mineral and lithium concentrate exports ahead of 2027 schedule, tightening global supply and lifting shares of Albemarle, Lithium Americas, SQM, and others amid rising lithium prices.
CAVA reports Q4 same-store sales +0.5% (beat estimates), forecasts 3-5% growth in 2026, plans 74+ new locations. Shares surge 16% as Mediterranean bowls win amid fast-casual slowdown.
